1 Market Overview
1.1 β-Nicotinamide Mononucleotide (NMN) Introduction
1.2 Market Analysis by Content
1.2.1 Overview: Global β-Nicotinamide Mononucleotide (NMN) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Above 98%
1.2.3 Below 98%
1.3 Market Analysis by Application
1.3.1 Overview: Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Health Care Products
1.3.3 Cosmetics
1.3.4 Others
1.4 Global β-Nicotinamide Mononucleotide (NMN) Market Size & Forecast
1.4.1 Global β-Nicotinamide Mononucleotide (NMN) Sales in Value (2016-2026))
1.4.2 Global β-Nicotinamide Mononucleotide (NMN) Sales in Volume (2016-2026)
1.4.3 Global β-Nicotinamide Mononucleotide (NMN) Price by Type (2016-2026) & (US$/Kg)
1.5 Global β-Nicotinamide Mononucleotide (NMN) Production Capacity Analysis
1.5.1 Global β-Nicotinamide Mononucleotide (NMN) Total Production Capacity (2016-2026)
1.5.2 Global β-Nicotinamide Mononucleotide (NMN) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 β-Nicotinamide Mononucleotide (NMN) Market Drivers
1.6.2 β-Nicotinamide Mononucleotide (NMN) Market Restraints
1.6.3 β-Nicotinamide Mononucleotide (NMN) Trends Analysis
2 Manufacturers Profiles
2.1 GeneHarbor
2.1.1 GeneHarbor Details
2.1.2 GeneHarbor Major Business
2.1.3 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Product and Services
2.1.4 GeneHarbor β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Herbalmax
2.2.1 Herbalmax Details
2.2.2 Herbalmax Major Business
2.2.3 Herbalmax β-Nicotinamide Mononucleotide (NMN) Product and Services
2.2.4 Herbalmax β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Genex Formulas
2.3.1 Genex Formulas Details
2.3.2 Genex Formulas Major Business
2.3.3 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
2.3.4 Genex Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Shinkowa Pharmaceutical
2.4.1 Shinkowa Pharmaceutical Details
2.4.2 Shinkowa Pharmaceutical Major Business
2.4.3 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Product and Services
2.4.4 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Maac10 Formulas
2.5.1 Maac10 Formulas Details
2.5.2 Maac10 Formulas Major Business
2.5.3 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Product and Services
2.5.4 Maac10 Formulas β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 EffePharm
2.6.1 EffePharm Details
2.6.2 EffePharm Major Business
2.6.3 EffePharm β-Nicotinamide Mononucleotide (NMN) Product and Services
2.6.4 EffePharm β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Bontac
2.7.1 Bontac Details
2.7.2 Bontac Major Business
2.7.3 Bontac β-Nicotinamide Mononucleotide (NMN) Product and Services
2.7.4 Bontac β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 CELFULL
2.8.1 CELFULL Details
2.8.2 CELFULL Major Business
2.8.3 CELFULL β-Nicotinamide Mononucleotide (NMN) Product and Services
2.8.4 CELFULL β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Kingdomway
2.9.1 Kingdomway Details
2.9.2 Kingdomway Major Business
2.9.3 Kingdomway β-Nicotinamide Mononucleotide (NMN) Product and Services
2.9.4 Kingdomway β-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 β-Nicotinamide Mononucleotide (NMN) Sales by Manufacturer
3.1 Global β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in β-Nicotinamide Mononucleotide (NMN)
3.4 Market Concentration Rate
3.4.1 Top 3 β-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share
3.4.2 Top 6 β-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share
3.5 Global β-Nicotinamide Mononucleotide (NMN) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and β-Nicotinamide Mononucleotide (NMN) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global β-Nicotinamide Mononucleotide (NMN) Market Size by Region
4.1.1 Global β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Region (2016-2026)
4.1.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2016-2026)
4.2 North America β-Nicotinamide Mononucleotide (NMN) Revenue (2016-2026)
4.3 Europe β-Nicotinamide Mononucleotide (NMN) Revenue (2016-2026)
4.4 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Revenue (2016-2026)
4.5 South America β-Nicotinamide Mononucleotide (NMN) Revenue (2016-2026)
4.6 Middle East and Africa β-Nicotinamide Mononucleotide (NMN) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Type (2016-2026)
5.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Type (2016-2026)
5.3 Global β-Nicotinamide Mononucleotide (NMN) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Application (2016-2026)
6.2 Global β-Nicotinamide Mononucleotide (NMN) Revenue by Application (2016-2026)
6.3 Global β-Nicotinamide Mononucleotide (NMN) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America β-Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2026)
7.2 North America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2026)
7.3 North America β-Nicotinamide Mononucleotide (NMN) Market Size by Country
7.3.1 North America β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Country (2016-2026)
7.3.2 North America β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2026)
8.2 Europe β-Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2026)
8.3 Europe β-Nicotinamide Mononucleotide (NMN) Market Size by Country
8.3.1 Europe β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Country (2016-2026)
8.3.2 Europe β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2026)
9.2 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2026)
9.3 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Market Size by Region
9.3.1 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific β-Nicotinamide Mononucleotide (NMN) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America β-Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2026)
10.2 South America β-Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2026)
10.3 South America β-Nicotinamide Mononucleotide (NMN) Market Size by Country
10.3.1 South America β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Country (2016-2026)
10.3.2 South America β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Type (2016-2026)
11.2 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales by Application (2016-2026)
11.3 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Market Size by Country
11.3.1 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa β-Nicotinamide Mononucleotide (NMN) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 β-Nicotinamide Mononucleotide (NMN) Typical Distributors
12.3 β-Nicotinamide Mononucleotide (NMN) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer